Visualizing cellularity and angiogenesis in newly-diagnosed glioblastoma with diffusion and perfusion MRI and FET-PET imaging

被引:8
|
作者
Liesche-Starnecker, Friederike [1 ]
Prokop, Georg [1 ]
Yakushev, Igor [2 ]
Preibisch, Christine [3 ]
Delbridge, Claire [1 ]
Meyer, Hanno S. [4 ]
Aftahy, Kaywan [4 ]
Barz, Melanie [4 ]
Meyer, Bernhard [4 ]
Zimmer, Claus [3 ]
Schlegel, Juergen [1 ]
Wiestler, Benedikt [3 ,5 ]
Gempt, Jens [4 ]
机构
[1] Tech Univ Munich, Sch Med, Inst Pathol, Dept Neuropathol, Munich, Germany
[2] Tech Univ Munich, Sch Med, Klinikum Rechts Isar, Dept Nucl Med, Munich, Germany
[3] Tech Univ Munich, Klinikum Rechts Isar, Sch Med, Dept Neuroradiol, Munich, Germany
[4] Tech Univ Munich, Sch Med, Klinikum Rechts Isar, Dept Neurosurg, Ismaningerstr 22, D-81675 Munich, Germany
[5] Tech Univ Munich, TranslaTUM Zentralinst Translat Krebsforsch, Einsteinstr 25, Munich, Germany
关键词
CELL-DENSITY; BRAIN; GLIOMAS; VOLUME; TUMORS;
D O I
10.1186/s13550-021-00817-3
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: Combining imaging modalities has become an essential tool for assessment of tumor biology in glioblastoma (GBM) patients. Aim of this study is to understand how tumor cellularity and neovascularization are reflected in O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography ([18F] FET PET) and magnetic resonance imaging (MRI) parameters, including cerebral blood volume (CBV), fractional anisotropy (FA) and mean diffusivity (MD). Methods: In this prospective cohort, 162 targeted biopsies of 43 patients with therapy-naive, isocitrate dehydrogenase (IDH) wildtype GBM were obtained after defining areas of interest based on imaging parameters [18F] FET PET, CBV, FA and MD. Histopathological analysis of cellularity and neovascularization was conducted and results correlated to imaging data. Results: ANOVA analysis showed a significant increase of CBV in areas with high neovascularization. For diffusion metrics, and in particular FA, a trend for inverse association with neovascularization was found. [18F] FET PET showed a significant positive correlation to cellularity, while CBV also showed a trend towards correlation with cellularity, not reaching significant levels. In contrast, MD and FA were negatively associated with cellularity. Conclusion: Our study confirms that amino acid PET and MR imaging parameters are indicative of histological tumor properties in glioblastoma and highlights the ability of multimodal imaging to assess tumor biology non-invasively.
引用
收藏
页数:6
相关论文
共 14 条
  • [1] Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET
    Werner, Jan-Michael
    Weller, Johannes
    Ceccon, Garry
    Schaub, Christina
    Tscherpel, Caroline
    Lohmann, Philipp
    Bauer, Elena K.
    Schaefer, Niklas
    Stoffels, Gabriele
    Baues, Christian
    Celik, Eren
    Marnitz, Simone
    Kabbasch, Christoph
    Gielen, Gerrit H.
    Fink, Gereon R.
    Langen, Karl-Josef
    Herrlinger, Ulrich
    Galldiks, Norbert
    CLINICAL CANCER RESEARCH, 2021, 27 (13) : 3704 - 3713
  • [2] Added value of amide proton transfer imaging to conventional and perfusion MR imaging for evaluating the treatment response of newly diagnosed glioblastoma
    Park, Kye Jin
    Kim, Ho Sung
    Park, Ji Eun
    Shim, Woo Hyun
    Kim, Sang Joon
    Smith, Seth A.
    EUROPEAN RADIOLOGY, 2016, 26 (12) : 4390 - 4403
  • [3] A Case of Cervical Spinal Cord Glioblastoma Diagnosed with MR Diffusion Tensor and Perfusion Imaging
    Liu, Xiang
    Germin, Barbara I.
    Ekholm, Sven
    JOURNAL OF NEUROIMAGING, 2011, 21 (03) : 292 - 296
  • [4] Methods for molecular imaging of brain tumours in a hybrid MR-PET context: Water content, T2*, diffusion indices and FET-PET
    Oros-Peusquens, A. M.
    Loucao, R.
    Zimmermann, M.
    Langen, K. -J.
    Shah, N. J.
    METHODS, 2017, 130 : 135 - 151
  • [5] Pre-irradiation tumour volumes defined by MRI and dual time-point FET-PET for the prediction of glioblastoma multiforme recurrence: A prospective study
    Harat, Maciej
    Malkowski, Bogdan
    Makarewicz, Roman
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 (02) : 241 - 247
  • [6] Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas
    Schoen, S.
    Cabello, J.
    Liesche-Starnecker, F.
    Molina-Romero, M.
    Eichinger, P.
    Metz, M.
    Karimov, I
    Preibisch, C.
    Keupp, J.
    Hock, A.
    Meyer, B.
    Weber, W.
    Zimmer, C.
    Pyka, T.
    Yakushev, I
    Gempt, J.
    Wiestler, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (06) : 1468 - 1475
  • [7] Added value of amide proton transfer imaging to conventional and perfusion MR imaging for evaluating the treatment response of newly diagnosed glioblastoma
    Kye Jin Park
    Ho Sung Kim
    Ji Eun Park
    Woo Hyun Shim
    Sang Joon Kim
    Seth A. Smith
    European Radiology, 2016, 26 : 4390 - 4403
  • [8] Radiotherapy Target Volume Definition in Newly Diagnosed High-Grade Glioma Using 18F-FET PET Imaging and Multiparametric MRI: An Inter Observer Agreement Study
    Dissaux, Brieg
    Mazouz Fatmi, Doria
    Ognard, Julien
    Allard, Bastien
    Keromnes, Nathalie
    Latreche, Amina
    Lepeuve, Amandine
    Schick, Ulrike
    Bourbonne, Vincent
    Ben Salem, Douraied
    Dissaux, Gurvan
    Querellou, Solene
    TOMOGRAPHY, 2022, 8 (04) : 2030 - 2041
  • [9] Short-interval estimation of proliferation rate using serial diffusion MRI predicts progression-free survival in newly diagnosed glioblastoma treated with radiochemotherapy
    Zaw, Taryar M.
    Pope, Whitney B.
    Cloughesy, Timothy F.
    Lai, Albert
    Nghiemphu, Phioanh L.
    Ellingson, Benjamin M.
    JOURNAL OF NEURO-ONCOLOGY, 2014, 116 (03) : 601 - 608
  • [10] Dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging parameters for predicting MGMT promoter methylation and prognostic value in newly diagnosed patients with glioblastoma
    Chida, Daiki
    Okita, Yoshiko
    Utsugi, Reina
    Kuroda, Hideki
    Hirayama, Ryuichi
    Kijima, Noriyuki
    Arisawa, Atsuko
    Kagawa, Naoki
    Kanemura, Yonehiro
    Yoshimura, Shinichi
    Tomiyama, Noriyuki
    Kishima, Haruhiko
    ONCOLOGY LETTERS, 2024, 28 (06)